Great China Biopharmaceutical Group

Great China Biopharmaceutical Group is a healthcare company that historically focused on the development and commercialization of Traditional Chinese Medicine (TCM) and natural health supplements. The company's product portfolio primarily featured botanical extracts derived from ginseng and cordyceps, which were marketed for general wellness and supportive care in chronic conditions. Headquartered in Shenzhen, China, with a legal incorporation in Nevada, the company operated through several subsidiaries, including Great China Biopharmaceutical (H.K.) Limited. Although it was previously traded on the OTC Pink market under the symbol GCBG, the company is currently considered inactive and has been designated as Dark or Defunct by market regulators. Its business model aimed to bridge traditional herbal remedies with modern pharmaceutical manufacturing standards to serve the Chinese healthcare market.